The Clinical Value of Circulating MicroRNAs in Acute Ischemic Stroke | ||
| Azhar International Journal of Pharmaceutical and Medical Sciences | ||
| Article 7, Volume 2, Issue 1, January 2022, Pages 66-72 PDF (275.37 K) | ||
| Document Type: Original research articles | ||
| DOI: 10.21608/aijpms.2021.79177.1078 | ||
| Authors | ||
| Aya Salman* 1; Shereen Elshaer1, 2; Ahmed El Shafei3; Olfat Shaker4 | ||
| 1Department of Biochemistry, Faculty of Pharmacy (Girls), Al-Azhar University, Cairo, Egypt | ||
| 2Department of Biochemistry, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt. | ||
| 3Department of Biochemistry and Molecular Biology, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt. | ||
| 4Department of Biochemistry and Molecular Biology, Faculty of Medicine, Cairo University, Cairo, Egypt. | ||
| Abstract | ||
| Acute ischemic stroke is one of the diseases causing death worldwide. MicroRNAs have pivotal roles in acute ischemic stroke pathogenesis, and their expression dysregulation, sensitivity and circulating stability could promote them as diagnostic biomarkers. So, this study aimed to examine the expression fold change and diagnostic accuracy potential of miR-601 and miR-760. The expression pattern of miR-601 and miR-760 in the serum of the 70 acute ischemic stroke patients in comparison to 25 age-matched control subjects was estimated using quantitative real time polymerase chain reaction. The receiver operator curve analysis was performed to determine the diagnostic potential of the studied microRNAs. Down-expression of miR-601 and miR-760 was found (94.8%; -1.16 ±1.05; 45; 75.8%; -0.525±0.936, respectively), the diagnostic accuracy was higher for miR-601 (AUC = 0.859), while the there was no diagnostic accuracy for miR-760. On comparing the studied miRNAs, miR-601 showed the best accuracy than miR-760 regarding the diagnosis of stroke. | ||
| Keywords | ||
| AIS; miRNA; miR-601; miR-760; Biomarker | ||
|
Statistics Article View: 294 PDF Download: 230 |
||
